Misuse of Drugs Act
Part II Class B Drugs
Source: L. A. King, Forensic Chemistry of Substance Misuse: A Guide to Drug Control, RSC Publishing, Cambridge, 2009
2
Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.
2A
Any ester or ether of cannabinol or of a cannabinol derivative or of a substance for the time being specified in paragraph 1(ac), (c) or (d) of this Part of this Schedule.
Effective 26 Feb 2013, S.I. 2013/239 replacement for:
On 8 Jan 2013, S.I. 2013/239* proposed replacement for:
Any ester or ether of cannabinol or of a cannabinol derivative or of a substance for the time being specified in paragraph 1(ac) or (c) of this Part of this Schedule.
Effective 13 Jun 2012, S.I. 2012/1390 replacement for:
On 28 Feb 2012, S.I. 2012/1390* proposed replacement for:
Any ester or ether of cannabinol or of a cannabinol derivative or of a substance for the time being specified in paragraph 1(c) of this Part of this Schedule.
Effective 23 Dec 2009, S.I. 2009/3209 replacement for:
Effective 26 Jan 2009, S.I. 2008/3130 added:
Any ester or ether of cannabinol or of a cannabinol derivative.
3
Any salt of a substance for the time being specified in paragraph 1, 2 or 2A of this Part of this Schedule.
Effective 26 Jan 2009, S.I. 2008/3130 replacement for:
Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.
4
Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.
11 March 2016 · Creative Commons BY-NC-SA ·